Executed in accordance with FDA human factors and usability engineering guidance, the study is intended to de-risk downstream regulatory review and support a streamlined path toward clinical development Raanana, Israel, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a pre-clinical-stage biotechnology company developing intranasal protective solutions, today announced the initiation of a key usability (Human Factors) study program for its lead product candidate, NASARIX™, an innovative intranasal allergy blocker designed for broad consumer use.

image for news Polyrizon Advances Regulatory Path with Initiation of Usability Study Program for NASARIX™ Allergy Blocker

The Range Nuclear Renaissance Index ETF has gained 58% over the past year, riding enthusiasm for nuclear power that's built since Microsoft and Amazon announced plans to power data centers with small modular reactors.

image for news NUKZ ETF Surges 58% as Nuclear Power Bets Face Trump Policy and Concentration Tests

Lexaria Awarded Six Additional Patents — Neutral

LEXX   TheNewswire — January 22, 2026

Lexaria now has 60 patents granted around much of the world Lexaria urges shareholders to vote at upcoming 2026 Annual Meeting

image for news Lexaria Awarded Six Additional Patents

GEORGE TOWN, CAYMAN ISLANDS / ACCESS Newswire / January 22, 2026 / Moolec Science S.A. ("Moolec" or the "Company") today announced that it has received a decision from the Nasdaq Hearings Panel (the "Panel") granting the Company an exception through June 29, 2026 to demonstrate compliance with the stockholders' equity requirement set forth in Nasdaq Listing Rule 5550(b)(1) (the "Stockholders' Equity Requirement"), subject to certain disclosure conditions.

image for news Moolec Science S.A. Receives Nasdaq Panel Exception Through June 29, 2026 to Regain Compliance with Stockholders' Equity Requirement

GALWAY, Ireland, Jan. 22, 2026 /PRNewswire/ -- TE Connectivity, a world leader in connectors and sensors, has earned a place on Fortune's World's Most Admired Companies list for the ninth consecutive year as an indication of its positive reputation among the global business community. "Innovation is advancing more quickly than ever before, so it is imperative that businesses have partners with strong engineering capabilities and commitment to excellence to help them compete and succeed," said CEO Terrence Curtin.

image for news TE Connectivity named to Fortune's World's Most Admired Companies list for ninth year

Lexaria Awarded Six Additional Patents — Neutral

LEXX   Accesswire — January 22, 2026

Lexaria now has 60 patents granted around much of the world Lexaria urges shareholders to vote at upcoming 2026 Annual Meeting KELOWNA, BC / ACCESS Newswire / January 22, 2026 / Lexaria Bioscience Corp. (Nasdaq:LEXX), (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to announce it has reached yet another important milestone in its strategy of building a strong and diverse intellectual property portfolio: the Company now has a total of 60 valid patents granted around most of the major potential markets around the world. Lexaria's previous update on patents was issued on October 9, …

image for news Lexaria Awarded Six Additional Patents

Expands Availability of Functional, Fermented Condiments to New Consumer Markets Expands Availability of Functional, Fermented Condiments to New Consumer Markets

image for news Edible Garden's New Distribution at Safeway Accelerates National Reach of Pickle Party™ and Pulp®

Philadelphia, Pennsylvania--(Newsfile Corp. - January 22, 2026) - National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against Integer Holdings Corporation (NYSE: ITGR) ("Integer" or the "Company") on behalf of investors who purchased or otherwise acquired Integer securities during the period of July 25, 2024 through October 22, 2025 (the "Class Period"), inclusive. Investor Deadline: Investors who purchased Integer securities during the Class Period may, no later than February 9, 2026, seek to be appointed as a lead plaintiff representative of the class.

image for news Integer Holdings Corporation (ITGR) Deadline Approaching: Berger Montague Advises Investors of Deadline in Securities Fraud Lawsuit

Marine Products: A Contrarian Setup, But The Stock Is Not Cheap — Neutral

MPX   Seeking Alpha — January 22, 2026

Marine Products Corp. is a leading motorboat manufacturer with a strong market presence. MPX is benefiting from a normalization in dealers' inventory dynamics. The historical link between consumer sentiment and MPX sales is weakening, reflecting a temporary transition to a mechanical demand as dealers readjusted inventory.

image for news Marine Products: A Contrarian Setup, But The Stock Is Not Cheap

Top 2 Tech Stocks That Are Ticking Portfolio Bombs — Negative

RFIL  UCTT   Benzinga — January 22, 2026

As of Jan. 22, 2026, two stocks in the information technology sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

image for news Top 2 Tech Stocks That Are Ticking Portfolio Bombs

Apple's Huge Surge in China — Positive

AAPL   24/7 Wall Street — January 22, 2026

Research firm Counterpoint has posted its smartphone data for China in the fourth quarter of 2025.

image for news Apple's Huge Surge in China

MRNA Stock: Why 16% Pop May Signal More Upside — Positive

MRNA   Forbes — January 22, 2026

image for news MRNA Stock: Why 16% Pop May Signal More Upside

How Broadcom Stock Delivered $51 Billion In Shareholder Value — Positive

AVGO   Forbes — January 22, 2026

Over the past decade, Broadcom (AVGO) stock has delivered an impressive $51 Bil back to its shareholders through cash distributions in the form of dividends and buybacks.

image for news How Broadcom Stock Delivered $51 Billion In Shareholder Value

Old Republic International (ORI) Q4 Earnings Lag Estimates — Negative

ORI   Zacks Investment Research — January 22, 2026

Old Republic International (ORI) came out with quarterly earnings of $0.74 per share, missing the Zacks Consensus Estimate of $0.89 per share. This compares to earnings of $0.9 per share a year ago.

image for news Old Republic International (ORI) Q4 Earnings Lag Estimates

Southern First (SFST) Tops Q4 Earnings Estimates — Positive

SFST   Zacks Investment Research — January 22, 2026

Southern First (SFST) came out with quarterly earnings of $1.21 per share, beating the Zacks Consensus Estimate of $1.11 per share. This compares to earnings of $0.7 per share a year ago.

image for news Southern First (SFST) Tops Q4 Earnings Estimates

What's Happening With Moderna Stock? — Positive

MRNA   Forbes — January 22, 2026

Moderna stock surged 16% yesterday after receiving promising clinical trial results for its experimental skin cancer vaccine. The firm is working on mRNA-1893/V940, a personalized cancer vaccine developed in collaboration with Merck, which yielded encouraging outcomes in minimizing melanoma recurrence when paired with Keytruda immunotherapy.

image for news What's Happening With Moderna Stock?

Starbucks Huge 2026 Rally — Positive

SBUX   24/7 Wall Street — January 22, 2026

One of the dogs of the stock market is in rally mode. Starbucks Corp. (NASDAQ: SBUX) stock is up almost 15% this year.

image for news Starbucks Huge 2026 Rally

Is Salesforce Stock At A Key Buying Opportunity? — Positive

CRM   Forbes — January 22, 2026

Salesforce (CRM) stock should be on your radar. Here's why – it is presently trading within the support range ($210.50 – $232.66), levels from which it has significantly rebounded in the past.

image for news Is Salesforce Stock At A Key Buying Opportunity?

How QuantumScape Stock Rises 2x To $22? — Positive

QS   Forbes — January 22, 2026

Following yesterday's 8% increase and an impressive 120% rise over the last year, QuantumScape stock (NASDAQ: QS) is priced at about $11. The question is: What could lead to a further doubling, pushing the stock beyond $22?

image for news How QuantumScape Stock Rises 2x To $22?

ELS Announces Tax Treatment Of 2025 Distributions — Neutral

ELS   PRNewsWire — January 22, 2026

CHICAGO, Jan. 22, 2026 /PRNewswire/ -- Equity LifeStyle Properties, Inc. (NYSE: ELS) (referred to herein as "we," "us" and "our") today announced the tax treatment of our 2025 common stock distributions. The following table summarizes the income tax treatment of our 2025 distributions.

image for news ELS Announces Tax Treatment Of 2025 Distributions